Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease

W. Stone, Gregg; A. Rizvi, Ali; Newman, William; Mastali, Kourosh; Wang, John; Caputo, Ronald; Doostzadeh, Julie; Cao, Sherry; A. Simonton, Charles; Sudhir, Krishnankutty; J. Lansky, Alexandra; E. Cutlip, Donald; J. Kereiakes, Dean

doi:10.1056/nejmoa0910496

Public

Everolimus-Eluting versus Paclitaxel-Eluting Stents in Coronary Artery Disease

Published in New England Journal of Medicine • May 5, 2010

Authors:

Gregg W. Stone

Ali A. Rizvi

William Newman

Abstract

BACKGROUND: Previous studies have established the superiority of coronary everolimus-eluting stents over paclitaxel-eluting stents with respect to angiographic findings. However, these trials were not powered for superiority in clinical end points. METHODS: We randomly assigned 3687 patients at 66 U...

Subject

Medicine

Paclitaxel

Everolimus

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!